{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:20:48Z","timestamp":1794835248138,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82472019"],"award-info":[{"award-number":["82472019"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Chongqing Technology Bureau","award":["CSTB2024TIAD-STX0048"],"award-info":[{"award-number":["CSTB2024TIAD-STX0048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1245\/s10434-026-20522-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:05:15Z","timestamp":1790334315000},"page":"11592-11603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delta 68Ga-Pentixafor PET\/CT Radiomics Models for the Detection of Surgically Curable Primary Aldosteronism"],"prefix":"10.1245","volume":"33","author":[{"given":"Rui","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangfu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Zhengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Hua","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"20522_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/hjh.0000000000002216","volume":"38","author":"S Monticone","year":"2020","unstructured":"Monticone S, Sconfienza E, D\u2019Ascenzo F, Buffolo F, Satoh F, Sechi LA, et al. Renal damage in primary aldosteronism: a systematic review and meta-analysis. J Hypertens. 2020;38:3\u201312. https:\/\/doi.org\/10.1097\/hjh.0000000000002216.","journal-title":"J Hypertens."},{"key":"20522_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/s2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9:876\u201392. https:\/\/doi.org\/10.1016\/s2213-8587(21)00210-2.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"20522_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916. https:\/\/doi.org\/10.1210\/jc.2015-4061.","journal-title":"J Clin Endocrinol Metab."},{"key":"20522_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension. 2018;71:317\u201325. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09975.","journal-title":"Hypertension."},{"key":"20522_CR5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, Zhang H, Wang H, Luo Y, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47:2656\u201365. https:\/\/doi.org\/10.1007\/s00259-020-04722-0.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"20522_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2023","unstructured":"Gao Y, Ding J, Cui Y, Li T, Sun H, Zhao D, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET\/CT. Eur Radiol. 2023;33:996\u20131003. https:\/\/doi.org\/10.1007\/s00330-022-09058-x.","journal-title":"Eur Radiol."},{"key":"20522_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"Wu X, Senanayake R, Goodchild E, Bashari WA, Salsbury J, Cabrera CP, et al. [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023;29:190\u2013202. https:\/\/doi.org\/10.1038\/s41591-022-02114-5.","journal-title":"Nat Med."},{"key":"20522_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/js9.0000000000003483","volume":"112","author":"G Zheng","year":"2026","unstructured":"Zheng G, Liu S, Gao Y, Yan X, Wang W, Zhao Y, et al. 68Ga-pentixafor PET\/CT versus adrenal venous sampling in guiding surgical management for primary aldosteronism: a prospective cohort study on postoperative outcomes. Int J Surg. 2026;112:844\u201353. https:\/\/doi.org\/10.1097\/js9.0000000000003483.","journal-title":"Int J Surg."},{"key":"20522_CR9","doi-asserted-by":"publisher","first-page":"e1363","DOI":"10.1210\/clinem\/dgad542","volume":"109","author":"A Vaidya","year":"2024","unstructured":"Vaidya A. The promise of nuclear imaging as an alternative to adrenal venous sampling for the detection of aldosterone-producing adenomas. J Clin Endocrinol Metab. 2024;109:e1363\u20134. https:\/\/doi.org\/10.1210\/clinem\/dgad542.","journal-title":"J Clin Endocrinol Metab."},{"key":"20522_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2967\/jnumed.121.261964","volume":"63","author":"J Ding","year":"2022","unstructured":"Ding J, Tong A, Zhang Y, Wen J, Zhang H, Hacker M, et al. Functional characterization of adrenocortical masses in nononcologic patients using 68Ga-Pentixafor. J Nucl Med. 2022;63:368\u201375. https:\/\/doi.org\/10.2967\/jnumed.121.261964.","journal-title":"J Nucl Med."},{"key":"20522_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399. https:\/\/doi.org\/10.1016\/s2213-8587(17)30135-3.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"20522_CR12","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2025;110:2453\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgaf284.","journal-title":"J Clin Endocrinol Metab."},{"key":"20522_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/hypertensionaha.118.11382","volume":"72","author":"TA Williams","year":"2018","unstructured":"Williams TA, Burrello J, Sechi LA, Fardella CE, Matrozova J, Adolf C, et al. Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension. 2018;72:641\u20139. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11382.","journal-title":"Hypertension."},{"key":"20522_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/hypertensionaha.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151\u201360. https:\/\/doi.org\/10.1161\/hypertensionaha.113.02097.","journal-title":"Hypertension."},{"key":"20522_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","volume":"14","author":"R Zuo","year":"2024","unstructured":"Zuo R, Liu S, Li W, Xia Z, Xu L, Pang H. Clinical value of (68)Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study. EJNMMI Res. 2024;14:61. https:\/\/doi.org\/10.1186\/s13550-024-01125-2.","journal-title":"EJNMMI Res."},{"key":"20522_CR16","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.Can-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-0125.","journal-title":"Cancer Res."},{"key":"20522_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41598-020-57427-7","volume":"10","author":"H Akai","year":"2020","unstructured":"Akai H, Yasaka K, Kunimatsu A, Ohtomo K, Abe O, Kiryu S. Application of CT texture analysis to assess the localization of primary aldosteronism. Sci Rep. 2020;10:472. https:\/\/doi.org\/10.1038\/s41598-020-57427-7.","journal-title":"Sci Rep."},{"key":"20522_CR18","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.acra.2023.10.015","volume":"31","author":"PT Chen","year":"2024","unstructured":"Chen PT, Li PY, Liu KL, Wu VC, Lin YH, Chueh JS, et al. Machine learning model with computed tomography radiomics and clinicobiochemical characteristics predict the subtypes of patients with primary aldosteronism. Acad Radiol. 2024;31:1818\u201327. https:\/\/doi.org\/10.1016\/j.acra.2023.10.015.","journal-title":"Acad Radiol."},{"key":"20522_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1244342","author":"N Mansour","year":"2023","unstructured":"Mansour N, Mittermeier A, Walter R, Schachtner B, Rudolph J, Erber B, et al. Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1244342.","journal-title":"Front Endocrinol."},{"key":"20522_CR20","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1210\/jc.2016-2986","volume":"102","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, et al. Histopathological classification of cross-sectional image-negative hyperaldosteronism. J Clin Endocrinol Metab. 2017;102:1182\u201392. https:\/\/doi.org\/10.1210\/jc.2016-2986.","journal-title":"J Clin Endocrinol Metab."},{"key":"20522_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.123.266061","volume":"65","author":"J Ding","year":"2024","unstructured":"Ding J, Li X, Liu S, Gao Y, Zheng G, Hacker M, et al. Clinical value of (68)Ga-Pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules. J Nucl Med. 2024;65:117\u201324. https:\/\/doi.org\/10.2967\/jnumed.123.266061.","journal-title":"J Nucl Med."},{"key":"20522_CR22","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, et al. Accuracy of Gallium-68 Pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6:e2255609. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55609.","journal-title":"JAMA Netw Open."},{"key":"20522_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, et al. The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism. J Clin Endocrinol Metab. 2023;109:171\u201382. https:\/\/doi.org\/10.1210\/clinem\/dgad421.","journal-title":"J Clin Endocrinol Metab."},{"key":"20522_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.15204","volume":"102","author":"R Zuo","year":"2025","unstructured":"Zuo R, Liu S, Ren X, Li W, Xia Z, Xu L, et al. Clinical utility of dual-time 68Ga-Pentixafor PET\/CT in diagnosing and subtyping primary aldosteronism. Clin Endocrinol. 2025;102:499\u2013509. https:\/\/doi.org\/10.1111\/cen.15204.","journal-title":"Clin Endocrinol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20522-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20522-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:36:08Z","timestamp":1794832568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20522-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["20522"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20522-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}